Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Pharmacy

 

Interview: Mike Wagner, Executive Director, The Advisory Board

We speak to Mike Wagner, executive director at healthcare consultancy The Advisory Board. Wagner believes there'll be a move towards a risk-segmented payor system that combines greater cost control for chronic patients and more service-oriented healthcare for the bulk of the population. Giving up old reservations and partnering with disruptive newcomers is key.

Puzzles in Aster DM’s red herring prospectus

Middle East and Indian hospitals to pharmacy chain Aster DM’s red herring IPO prospectus begs as many questions as it answers. Why is EBITDA so low? Will its founder escape criminal charges? Why does it not include full financial year data? So how can it be worth 16,000 crores (an eye watering $2.4bn), that is more than Narayana and Fortis put together?

UK healthcare faces up to Brexit

The UK has voted to leave the EU unleashing economic and political turmoil that has taken the legs out from under Sterling, ignited press hysteria and will likely see the leaders of both major parties replaced. As always, the NHS was front and centre during the campaign. But concerns for healthcare more broadly, including the private sector, are numerous. We talk to investors, operators and advisors.

Aster DM expands hospital and pharmacy networks

UAE-based Aster DM is to open two 100-bed hospitals in the emirates of Sharjah and Dubai over the next three months –as part of $100m investment. Each hospital cost between $40m (AED150m) to $54m (AED200m). The group is also planning to build four other hospitals in the next two years.

Ping An Doctor app to bridge payer-provider gap in China

One year after its launch, Chinese insurer Ping An’s comprehensive ‘Doctor’ app raised $500m in a series A funding round. The app allows its users to access real-time consultations and health management services –becoming the most popular platform in a saturated digital market. We look at Ping An’s strategy to bridge the payer-provider gap.

Apollo’s expansion plans stumble on regulations

Apollo Hospitals is proposing a Rs 750 crore ($112m) rights issue to fund its five-year plan to expand its hospital network. But after a first failed attempt in October 2015, India's Foreign Investment Promotion Board (FIPB) is turning down Apollo's proposal again.

Rival Filipino conglomerates Ayala Corp. and MPIC pour millions into healthcare

Ayala Corp., one of the largest conglomerates in the Philippines, is to launch a network of 100 outpatient clinics in the next three years. Called FamilyDoc, these facilities will contain a pharmacy as well as diagnostics and lab units – even a shop, aiming to cater for the primary care needs of a growing middle class. And it is not the only one looking into healthcare.

Jeremy Hunt plans bigger role for pharmacies

Jeremy Hunt, Secretary of State for Health in the UK, plans to give pharmacies a much bigger role in care, say sources who say he plans to circumvent the Pharmaceutical Services Negotiating Committee, powerful body in which the large chains, such as Boots, are strongly represented.

“Beyond the pill” pharma fails to convince

Big pharma is trying and failing to engage with patients and has no idea how to build service models. Previous attempts to create websites that directly engage with consumers have flopped. The appallingly-named “patient-centricity” sessions at the FT Global Pharmaceutical and Biotechnology Conference suggest pharma is still trying in vain.

Report: Private Healthcare in Mexico – Hotting Up

Mexico boasts a large, innovative and vibrant private healthcare sector, which sits alongside a developing, but somewhat chaotic public sector. We look at the major players in the private sector, as well as at new innovators seeking to cut the cost of treatment to reach the masses.

Find Us